A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Running, not enrolling

Conditions studied: Alzheimer Disease, Mild Cognitive Impairment

In brief

The purpose of this study is to learn about health care use, costs, and clinical outcomes over time for amyloid positive participants with early stages of AD in the United States. This study is for research purposes only, and is not intended to treat any medical condition. No study therapy(ies) for AD will be administered.

Key facts

Study ID
NCT02951598
Run by
Eli Lilly and Company
People needed
1400
Starts
2016-10-29
Expected to finish
2026-04-28
Last updated by the study team
2025-10-24

Who can join

Age: 55 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.